A Tough Spot for Biotech ETFs

Market observers are abuzz regarding the recent weakness in biotechnology stocks and the related exchange traded funds. It is easy to understand why. Healthcare is this year’s top-performing sector after being second-best last year, which is to say the group has been an important driver of U.S....